British Columbia switching Rituxan rituximab patients to biosimilars
About 1,600 B.C. PharmaCare patients who take the drug Rituxan rituximab will have six months to switch to a rituximab biosimilar. The $30.7 million saved over three years will be reinvested into patient care.